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Abstract
Background: Substantial amounts of data on cell signaling, metabolic, gene regulatory and other
biological pathways have been accumulated in literature and electronic databases. Conventionally,
this information is stored in the form of pathway diagrams and can be characterized as highly
"compartmental" (i.e. individual pathways are not connected into more general networks). Current
approaches for representing pathways are limited in their capacity to model molecular interactions
in their spatial and temporal context. Moreover, the critical knowledge of cause-effect relationships
among signaling events is not reflected by most conventional approaches for manipulating
pathways.
Results: We have applied a semantic network (SN) approach to develop and implement a model
for cell signaling pathways. The semantic model has mapped biological concepts to a set of semantic
agents and relationships, and characterized cell signaling events and their participants in the
hierarchical and spatial context. In particular, the available information on the behaviors and
interactions of the PI3K enzyme family has been integrated into the SN environment and a cell
signaling network in human macrophages has been constructed. A SN-application has been
developed to manipulate the locations and the states of molecules and to observe their actions
under different biological scenarios. The approach allowed qualitative simulation of cell signaling
events involving PI3Ks and identified pathways of molecular interactions that led to known cellular
responses as well as other potential responses during bacterial invasions in macrophages.
Conclusions: We concluded from our results that the semantic network is an effective method
to model cell signaling pathways. The semantic model allows proper representation and integration
of information on biological structures and their interactions at different levels. The reconstruction
of the cell signaling network in the macrophage allowed detailed investigation of connections
among various essential molecules and reflected the cause-effect relationships among signaling
events. The simulation demonstrated the dynamics of the semantic network, where a change of
states on a molecule can alter its function and potentially cause a chain-reaction effect in the system.
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Background
Interactions among genes, gene products and small mole-
cules regulate all cellular processes involving cell survival,
cell proliferation, and cell differentiation among others.
Such interactions are organized into complex lattice struc-
tures conventionally divided into cell signaling, metabolic
and gene regulatory networks in a cell [1]. In recent years,
large amounts of information and knowledge on cell sig-
naling networks have been accumulated in the literature
and databases [2,3].
Conventionally, this information is highly compartmen-
tal: various individual signaling pathways are mostly
stored in separated and non-linked diagrams. Traditional
pathway diagrams, where molecules are represented as
nodes and their interactions are depicted as lines and
arrows have significant limitations as they lack spatial and
temporal context [4]. Moreover, the critical knowledge of
cause-effect relationships among signaling events is not
reflected by most conventional approaches for manipulat-
ing pathways. Not surprisingly, the current state of path-
way representation does not allow of complex
investigation of qualitative or quantitative changes in cell
signaling networks in response to external perturbations
such as bacterial infections. Thus, an adequate computa-
tional environment for modeling cell signaling networks
is needed for proper biological data integration as well as
for simulation and prediction of cellular behaviors [5].
Recently, many models have been proposed for represent-
ing, storing and retrieving interactions among various bio-
logical entities. BIND [6] and IntAct [7] focus on protein-
protein interactions and their resulting complexes. BioCyc
[8] developed models for metabolic events and curated
metabolic pathways from many organisms. The model
developed by aMAZE [9] combines interactions in cell-sig-
naling, metabolic and gene regulatory pathways. In addi-
tion, the System Biology Markup Language (SBML) has
been developed for representing biochemical reaction
networks and for communicating models used for various
simulation programs [10]. Programs such as E-cell [11],
Gepasi 3 [12] and Virtual Cell [13] use differential equa-
tions to represent molecular interactions, and their simu-
lation results are obtained by solving these questions
numerically [14]. It should be noted, however, that many
cellular processes are sensitive to the stochastic behavior
of a small number of molecules, and therefore, the
assumptions in differential-equation methods can often
be compromised [15]. Several studies have attempted to
address the stochastic property of a cell. Vasudeva and
Bhalla [16] proposed a hybrid simulation method that
combined both deterministic and stochastic calculations.
In addition, a stochastic simulator, StochSim [15] repre-
sented molecules as individual software objects that inter-
act according to probabilities. Thus, it is feasible to suggest
that useful cell signaling simulators should be capable of
representing each molecule individually and reflecting the
stochastic behavior of molecular interactions in a cell.
Semantic networks
Recently an artificial intelligence approach known as
semantic networks (SN) have gained the attention of the
biological community as a potentially powerful tool for
organizing and integrating large amounts of biological
information [17]. For instance, the semantic network in
the Unified Medical Language System (UMLS) was
designed to retrieve and integrate biomedical information
from various resources [18]. The UMLS semantic network
has also been applied and expanded to include informa-
tion and knowledge from other domains such as genom-
ics [19]. In addition, other studies have suggested a
semantic approach where proteins are viewed as "adaptive
and logical agents", whose properties and behaviors are
affected by other agents in their spatial organization
including intracellular compartments and protein com-
plexes [20,21]. Defining the semantics among agents
could characterize both local and global behaviors of a
system, and therefore, it is potentially useful to apply such
approach to study cell signalling in biological systems
[21].
A semantic network is a method to represent information
or knowledge by nodes and edges in a graphic form,
where a node represents a concept and an edge represents
a relationship [22]. A semantic network, which can exist
abstractly in a human mind or be implemented by apply-
ing computer technology, can model many real-world
problems [22]. Figure 1 illustrates a semantic network,
where a concept such as a protein, a chemical reaction or
a subcellular location is modeled by a semantic agent, and
its relationships with other agents are represented as
arrows. A proper semantic network implementation
allows the identity and properties of an agent to arise from
its relationships with other agents, not from descriptions
or labels [23]. Hence, within a semantic network "things
are what they do".
Previously an application development environment
known as Visual Knowledge (VK) has been created, and
VK is capable of different formalizations and implementa-
tions of semantic networks for various knowledge
domains [23]. Visual Knowledge has been applied suc-
cessfully to model and manipulate complex "interac-
tomes", including corporate enterprise systems, flight
scheduling networks, hardware maintenance simulators,
and integrated currency exchange boards [23]. It has been
anticipated that Visual Knowledge can address many of
the current limitations on modeling cell signaling path-
ways. Using the latest VK-based environment, BioCAD
[24], specifically designed for biological applications, weBMC Bioinformatics 2004, 5:156 http://www.biomedcentral.com/1471-2105/5/156
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have developed a semantic model for cell signaling path-
ways occurring in human macrophages.
Bacterial invasions in macrophages
It is the current knowledge that many pathogenic bacteria
are capable of entering and surviving within mammalian
macrophages by modulating the host signaling pathways
[25]. One well-studied example is the activation of the Fcγ
macrophage receptor by the IgG antibody, which binds to
the surface of bacteria such as Mycobacterium tuberculo-
sis [26]. Activation of the Fcγ receptor induces phagocyto-
sis of M. tuberculosis and the formation of a phagosome
within the macrophage. These processes are mediated by
the class I phosphoinositide 3-kinase (PI3K) – one of the
most well-characterized enzymes to date [27]. The class I
PI3K is a heterodimer composed a p110 catalytic subunit
and a p85 regulatory subunit, which maintains a low-level
activity of p110 [28]. The p110 subunit is activated when
p85 binds at a phosphotyrosine site on a receptor or an
adaptor protein, or by direct binding to activated Ras [29].
Activated PI3K-p110 phosphorylates phosphatidylinosi-
tol-4,5-bisphosphate (PIP2) into phospatidylinositol-
3,4,5-trisphosphate (PIP3), which is an essential signaling
molecule that stimulates many downstream proteins,
including PDK1 and Akt [30]. The formation of a phago-
some is normally followed by the phagosome maturation
process, which is responsible for intracellular killing of
bacteria and is regulated by the class III PI3K [31]. How-
ever, it has been hypothesized that phosphatidylinositol
analogs, such as ManLAM, produced by M. tuberculosis
can inhibit the activity of the class III PI3K, arresting
phagosome maturation process, and ensuring the survival
of M. tuberculosis inside the macrophage [27,32].
In addition to their role in phagocytosis, PI3Ks are essen-
tial proteins that regulate cell survival, cell growth, cell
cycle and other cellular processes [33]. Although, it is clear
that PI3Ks play an important role in bacterial invasions,
the knowledge of PI3K-mediated interactions is scattered
in a number of literature and pathway databases. A coher-
ent picture of detailed molecular interactions that link
receptors to PI3Ks and to various cellular responses has
yet to be constructed before bacterial invasions can be
fully understood. To address this goal, a cell signaling net-
work of the human macrophage was reconstructed with
the semantic model, and qualitative changes in the net-
work were investigated with a SN-simulator.
Results
A semantic model for cell signaling pathways
In the paper, the word "model" refers to a set of rules in
two different but related contexts. In the context of the
semantic network, the model refers to a set of rules that
specify how a biological concept is mapped to one or mul-
tiple semantic agents/relationships. In the context of cell
signaling pathways, the model is a set of rules that specify
what, how, and when molecules interact with each other.
The model has been formalized and implemented, using
BioCAD software system, and it is presented in the follow-
ing sections.
Overall classification of biological structures and their relationships
Within the semantic network, all biological structures are
modeled by semantic agents that are members in one of
the 6 different prototypes. Table 1 shows the 6 types of
structures in the order of their hierarchy. From the highest
to the lowest level, they are "Cell", "Subcellular Compart-
ment", "Macromolecule", "Domain/Site", "Small Mole-
cule/Molecular Fragment", and "Atom". A structure agent
can be composed of multiple structures of the same pro-
totype or a lower-level prototype, and the agent is con-
nected to its components by the composition relationship
in the SN. Thus, a human macrophage has been modeled
as a semantic agent of the "Cell" prototype, and it was
composed of various "Subcellular Compartment" agents,
including plasma membrane, cytosol, nucleus and others.
In addition, each compartment such as nucleus contained
various agents of the "Macromolecule" prototype includ-
ing proteins, DNA and RNA. A macromolecule such as a
protein was further composed of "Domain/Site" agents
like catalytic domains and phosphorylation sites, and a
DNA was composed of sites such as promoters and gene
regulatory sites.
An example of a semantic network Figure 1
An example of a semantic network. Characteristics and 
behaviors of a semantic agent (SA) are defined by its relation-
ships (RE) with other agents. Semantic agents are repre-
sented as circles, and relationships are depicted as arrows. 
This SN-model represents that a protein A can be located at 
a nucleus, can interact with a protein B or catalyze a chemical 
reaction. For explanatory purpose, this figure illustrates an 
example of a semantic network. The implemented semantic 
network (as presented in the paper) is more complex and 
involves different types of relationships and agents.BMC Bioinformatics 2004, 5:156 http://www.biomedcentral.com/1471-2105/5/156
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Modeling interactions among biological structures
To create an adequate semantic model, we have postu-
lated that structures of different levels in the cellular hier-
archy can interact with one another. One example of such
interactions is the movement of a molecule from one sub-
cellular compartment (e.g. cytosol) to another (e.g.
plasma membrane). This is referred to as a translocation
event, and it is demonstrated on the left panel of Figure 2.
Table 2 shows that translocations have been modeled as
one the five major "event" prototypes in the SN. Every
translocation event has been connected to three structure
agents: a molecule to be moved (macromolecule or small
molecule), an original location (subcellular compart-
ment), and a destination (subcellular compartment).
Hence, the construction of translocation events has ena-
bled us to confine all possible movements of molecules in
a cell.
Interactions that occur by non-covalent or covalent forces
have also been modeled as two distinct "event" proto-
types as shown in Table 2. The right panel of Figure 2 illus-
trates a general case of a molecular interaction between a
protein A and a protein B occurring via non-covalent
forces. Such interaction can cause changes of the forms
and functions of the interacting molecules, and these
changes have been accommodated within the developed
SN model by specifying two distinct types of states: "con-
formational states" and "binding states", also represented
by semantic agents.
All hypothetical spatial changes occurring in the three-
dimensional structure of a given macromolecule have
been modeled within the SN as switches in the corre-
sponding conformational states, and the changes do not
lead to the creation of new semantic agents. Domains or
sites for every protein encoded into the SN model have
Table 1: Classification of biological structures in 6 prototypes in the semantic network.
Semantic Agent – Structure Biological Example
Cell Human macrophage, Mycobacterium tuberculosis
Subcellular Compartment Plasma membrane, cytosol, phagosome, nucleus
Macromolecule Protein, nucleic acid, polysaccharide, fat/lipid
Domain and Site Catalytic domain, SH2 domain, PH domain, binding site, phosphorylation site, promoter, gene 
regulatory site.
Small Molecule and Molecular Fragment Amino acid, nucleotide, sugar, fatty acid
Atom Hydrogen, carbon, oxygen, nitrogen, phosphorus, sulfur
Table 2: Classification of biological events in 5 prototypes in the semantic network.
Semantic Agent – Event Biological Example
Translocation A protein moves from cytosol to plasma membrane.
Non-covalent Interaction A ligand binds to a receptor.
Covalent Interaction An enzyme catalyzes a chemical reaction where substrates are converted to products.
Allosteric Regulation A ligand binding on site A of a protein causes a conformational change on site B of the protein.
Cellular Response Cell survival, cell death, phagosome formation, increase of intracellular glucose level.
Interactions among biological structures of different levels in  the SN Figure 2
Interactions among biological structures of different levels in 
the SN. The left panel shows an example of a translocation 
event when a protein B is moved from the cytosol to the 
plasma membrane. The right panel shows an example of a 
non-covalent interaction between a protein A and a protein 
B via non-covalent forces.BMC Bioinformatics 2004, 5:156 http://www.biomedcentral.com/1471-2105/5/156
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been assigned to either "Functional" or "Non-functional"
conformational states. The "Functional" state represents
that a domain/site is currently in a conformation that ena-
bles a certain interaction. On the other hand, a "Non-
functional" state implies a domain/site is in a conforma-
tion that prevents an interaction. To illustrate this
construct we have graphed the semantic agents and their
relationships created within the developed SN. It should
be noted that within the SN, all semantic agents are visu-
alized as icons, and their relationships are depicted as
connecting arrows. In addition, all agents are related by
pairs of reciprocal relationships, and for simplicity, only
one direction of each pair of the relationships was visual-
ized. The left panel of Figure 3 features a p110 subunit of
the class I PI3K that has been modeled as a "macromole-
cule" agent and contains a binging site for a Ras protein
and a catalytic domain. The Ras binding site has been
assigned a state of "Functional", depicted as a check sym-
bol (square) on Figure 3. The "Functional" state enables
the PI3K-p110 to bind to a Ras protein. On the other
hand, the catalytic domain is "Non-functional', depicted
as a cross symbol. Figure 8 shows the description of icons
used in this paper.
In addition to the conformational states, a protein
domain or site has been assigned one of the two binding
states: "Bound" or "Not-bound". A "Bound" state implies
that this domain/site currently associates with a domain/
site of another molecule through a non-covalent interac-
tion. On the other hand, a "Not Bound" state indicates
such an association does not exist. Since ligand bindings
can affect the conformation of a macromolecule through
allosteric regulations, two types of such regulations have
been implemented within the SN. A positive allosteric reg-
ulation event has been assigned to the scenario when a
"Bound" binding state of a domain/site causes the confor-
mational state of another domain/site to switch to "Func-
tional". The right panel of Figure 3 shows that when the
PI3K-p110 has bound to a Ras by a non-covalent interac-
tion, the binding state of the Ras-binding site on p110 has
switched to "Bound". As a result, the conformational state
of the catalytic domain has switched to "Functional" due
to a positive allosteric regulation. The "Functional" cata-
lytic domain now enables the PI3K-p110 to phosphor-
ylate its substrate. On the other hand, a negative allosteric
regulation event has been attributed to those cases when
a "Bound" state of a domain/site causes the conforma-
tional state of another domain/site to switch to "Non-
functional". It should be noted that the semantic model
stores the information that specifies the non-covalent
event between the prototypic Ras and the prototypic PI3K-
p110, and the condition for the event to occur. Figure 3
illustrates an instance of the Ras-binding event occurred
during a simulation. The PI3K-p110 is an instance of the
PI3K-p110 prototype, and it is the same agent before and
after it binds to the Ras.
A more complex allosteric regulation event can be speci-
fied for mapping the binding states of multiple domains/
sites (the condition or the input) to the conformational
states of multiple domains/sites (the response or the out-
put). Hence, a domain is switched to "functional" only if
a certain combination of ligand bindings has occurred.
The utilization of the states on domains/sites and allos-
teric regulation events in the SN has enabled us to express
the cause-effect relationships among various signaling
events explicitly.
In the developed semantic model, any molecular complex
formed due to non-covalent interaction has been treated
as a transient state of these two molecules, and a complex
was not represented by a new semantic agent. Instead, the
existence of a protein complex is inferred from the non-
covalent interaction event. Thus, Figure 3 illustrates a pro-
tein complex of the PI3K-p110 and the Ras existed
A model of a non-covalent interaction between a PI3K-p110  and a Ras Figure 3
A model of a non-covalent interaction between a PI3K-p110 
and a Ras. The figure was graphed from the developed SN to 
illustrate the relationships among different agents. The figure 
visualizes the agents as icons and their relationship as arrows. 
The left panel illustrates that a PI3K-p110 contains a "Not 
Bound" Ras-binding site and a "Non-Functional" catalytic 
domain. The right panel shows that when the PI3K-p110 has 
bound to a Ras, its Ras-binding site has switched to "Bound", 
and the catalytic domain has become "Functional" due to a 
positive allosteric regulation event. State changes as a result 
of the interaction are shown in bold. Note that the model 
stores the information, which specifies the non-covalent 
event between the prototypic Ras and the prototypic PI3K-
p110, and the condition for the event to occur. This figure 
illustrates an instance of the Ras-binding event occurred dur-
ing a simulation. The PI3K-p110 is an instance of the PI3K-
p110 prototype, and it is the same agent before and after it 
binds to the Ras. Figure 8 shows the description of each icon.BMC Bioinformatics 2004, 5:156 http://www.biomedcentral.com/1471-2105/5/156
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because of the occurrence of the non-covalent interaction
event, which connected the two molecules.
Conventionally, there is often some inconsistency
between representing chemical modifications of small
molecules in metabolic pathways and modifications of
proteins in signaling pathways. In the developed model,
two molecules that interacted by covalent forces have
resulted the creation of distinct semantic agents within the
SN. This rule has been implemented consistently for both
macromolecules such as proteins and small molecules
such as ATP. As one example, Figure 4 features the phos-
phorylation of an Akt protein by an enzyme PDK1,
yielding a distinct Akt-phosphate (Akt-P) agent and a free
ADP. Within the SN, the Akt and the ATP are related to a
covalent interaction event by "Substrate" relationships,
depicted as arrows. In addition, the Akt-P and the ADP are
related to the event by "Product" relationships, while the
PDK1 is related by the "Enzyme" relationship. The PDK1
enzyme in this example contains a catalytic domain (not
shown on the figure), which must be "functional" for the
reaction to occur. The state of this domain is under the
regulation of the binding of a ligand and an allosteric
event as previously defined. In addition, new properties
can be assigned to the modified protein. In this case, the
phosphorylation by PDK1 switched the catalytic domain
in Akt-P to "functional", while this domain was "non-
functional" in Akt, the dephosphorylated form. Figure 4
illustrates that a covalent interaction event also applies to
metabolites, and a metabolite such as glucose is phospho-
rylated into a glucose-6-phosphate by an enzyme
Hexokinase. Other types of modifications including
methylation, acetylation and glycosylation can also be
modeled in a similar manner but involve different sub-
strate types.
In the semantic model, a molecule can participate in dif-
ferent sets of interactions in different locations. The trans-
location events define all possible localizations of
molecules, and therefore, an interaction can only occur if
the participating molecules can be present in the same
location at the same time. Alternatively, an interaction
(non-covalent or covalent) can directly associate with a
subcellular compartment, and this interaction is only
available to molecules in that location.
In addition, all qualitative cellular responses such as cell
survival and phagosome formation have been imple-
mented within the SN under a distinct "event" prototype.
They have been implemented in a way that the formation
or the activation of certain signaling molecules such as
PIP3 can trigger the occurrence of these cellular response
events in a simulation.
As it has been mentioned previously, the behavior of any
semantic agent can be clearly defined by its relationships
or connections to other agents. Thus, the formalization of
the five types of events, which are translocations, non-cov-
alent interactions, covalent interactions, allosteric regula-
tions and cellular responses, has enabled us to model the
behaviors of molecules depicted in conventional path-
ways and to reconstruct a cell signaling network of the
human macrophage.
Case study: a reconstruction of a cell signaling network in 
the macrophage
Data source
The molecular composition of human macrophages and
information of known intracellular interactions have
been extracted from various research articles
A model for covalent interactions Figure 4
A model for covalent interactions. Figure 4a shows that an 
Akt protein can be phosphorylated to an Akt-phosphate by 
an enzyme, PDK1, and an ATP is converted to an ADP in the 
process. Figure 4b shows a similar covalent interaction event 
where substrate Glucose can be converted to Glucose-6-
phosphate by an enzyme Hexokinase.BMC Bioinformatics 2004, 5:156 http://www.biomedcentral.com/1471-2105/5/156
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[26,27,32,34-47], review articles [25,28-31,33,48-52] and
pathway databases [2,3].
Translation and integration of pathway information into the semantic 
model
A pathway diagram in the literature or an electronic data-
base, in principle, represents some scenario of what may
happen in a call if every depicted molecule is expressed in
the correct location, at the correct time and with the cor-
rect states. Hence, the aggregation of multiple pathway
diagrams describes some, if not all, possible molecular
events that can potentially occur in a cell under the right
conditions. To utilize such information and build a cell
signaling network, we have decomposed conventional
pathways into individual pieces of information such as
subcellular localization of a protein, a pairwise protein
binding, a chemical reaction or a cellular response. Then,
using the sets of semantic rules described in the model, we
have represented and integrated each piece of those infor-
mation in the form of semantic agents and their relation-
ships. Table 3 illustrates the overall SN model for the cell
signaling network contained a total of 93 prototypical
macromolecules localized in several subcellular compart-
ments. It included several cell receptors (such as Fcγ, CR3,
CD 14, CD18, TLR2) relevant to the process of bacterial
internalization of macrophages. Two distinct classes of
PI3Ks have been modeled: the class I PI3K composed of
p85 regulatory and p110 catalytic subunits, and the class
III PI3K composed of p150 and Vps34p subunits [28]. The
model also included various kinases such as Lyn, PDK1
and Akt, small GTPases including Ras, Rac1 and Rab5,
and adaptor proteins like Gab2. Events of various proto-
types have also been extrapolated from the literature and
pathway diagrams.
Visualization and analysis of the cell signaling network
The defined semantic agents have been connected in the
semantic network and can be visualized at different levels.
Figure 5 shows one example of how various non-covalent
and covalent interactions have been integrated into a
unified cell signaling network. The longest path in the cell
signaling network we have created contained 24 consecu-
tive molecular interaction events, linking Fcγ receptor to
the class I PI3K enzyme and further through class III PI3K
to various cellular responses.
Such detailed semantic reconstruction of the cell signaling
network has allowed thorough investigation of biochem-
ical relationships between essential proteins. One such
example is presented on Figure 5 featuring the connec-
tions among cell receptors Fcγ and CR3, and tyrosine
kinase Lyn which they both activate. It has also been
reconstructed by the SN model that both of these
receptors can activate the class I PI3K via an adaptor pro-
tein, Gab2. The corresponding finding will now be sub-
jected to testing in an experimental lab.
Another example of successful SN reconstruction is the
relationship between CD14 macrophage receptor and the
class I PI3K; such a relationship was previously suspected
but not clear [39]. By incorporating the available literature
data [35,45] into the semantic environment we were able
to reconstruct the scenario where CD14 activates the class
I PI3K by the association of Toll-like receptor 2 (TLR2), as
it is illustrated in Figure 5. Such model will also be tested
experimentally.
Simulation of changes in the cell signaling network during 
bacterial invasions
In the implemented semantic model, the "possible"
behaviors of a molecule are defined through its relation-
ships to other agents (for example a non-covalent event),
and all instances of that prototypical molecule will inherit
the same behaviors. However, the action of a molecule at
any given time is affected by factors including its current
states and its current location with respect to other
molecules in the system. Hence, we have built an applica-
tion that enabled us to produce instances of molecules in
Table 3: The number of structure and event prototypes modeled in the cell signaling network of the macrophage.
Structure Sum
Subcellular Compartment 9
Macromolecule 93
Domains and Site 20
Small Molecule 9
Event Sum
Translocation 24
Non-covalent Interaction 57
Covalent Interaction 28
Cellular response 22BMC Bioinformatics 2004, 5:156 http://www.biomedcentral.com/1471-2105/5/156
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various locations and to observe the "current" action of a
molecule qualitatively under different biological scenar-
ios. We refer such scenario-play as simulation in this
paper.
The application or the SN-simulator allows the molecules
to move among various locations, to interact with each
other and to create events when the conditions are met. In
addition, every instance of a molecule has been
represented as an individual agent while every instance of
a molecular interaction has also been implemented as an
individual event agent. Thus, the simulator provides a
traceable "trajectory" of all the events that have happened
on every molecule during a simulation.
As illustrated in Figure 6, the macrophage cell has been
generally divided into four subcellular compartments or
locations within the simulator. We have specified what
molecules to be present initially in each subcellular loca-
tion in the beginning of a simulation, and the simulator
synthesized molecules in each location accordingly. At the
very first simulation step, the simulator has created a
translocation event moving a molecule (the current tar-
get) from one location to another. The initial transloca-
tion has been specified as the movement of an IgG
molecule from the extracellular space to the plasma mem-
brane as shown in the pathway-viewer on Figure 6. The
occurrence of this initial event allowed the simulator to
trigger a search and advanced to the next step. The search
looked for other potential molecules (with the correct
states) that can interact with the target molecule in the
same location. If multiple instances of potentially inter-
acting molecules were present in that location, a single
molecule would be randomly selected to interact with the
target.
Because an Fcγ receptor was the only interacting molecule
(for the IgG) present at plasma membrane in the simula-
tion, it has bound to the IgG by a non-covalent interaction
event, as illustrated in Figure 7. This non-covalent interac-
tion has switched the state of the Fcγ receptor's binding
site for a Lyn kinase to "Functional", and thus it enabled
the Fcγ receptor to bind to a Lyn. However, the Lyn was
not initially present in plasma membrane, but it was
localized in cytosol in the beginning of the simulation, as
shown in Figure 6. Thus, when the Lyn has been translo-
cated from the cytosol to the plasma membrane, a non-
covalent interaction between the Lyn and the "Func-
tional" Fcγ receptor occurred in the following step as
shown in Figure 7. The search was iterated and the simu-
lation continued until all interacting molecules have been
depleted in the macrophage.
Figure 7 demonstrates the consecutive events in this sim-
ulation scenario where the Lyn protein phosphorylated a
Gab2, which then bound to a class I PI3K. When acti-
vated, the PI3K phosphorylated a PIP2 into a PIP3, which
in turn caused a phagosome formation response. Differ-
ent setups of the initial localization of molecules have
affected the outcome of the simulation. For instance, an
initial presence of a Rab5 (a downstream protein of the
PIP3) and a class III PI3K in the cytosol extended the pre-
vious pathway from the PIP3. This localization setup
stimulated a PIP3-mediated activation of the class III
PI3K, which led to phagosome maturation response in the
simulation. However, if a phosphatidylinositol analog,
ManLAM, of M. tuberculosis was initially present in the
plasma membrane, it would inhibit the class III PI3K and
thus arrest the phagosome maturation response in the
macrophage. Table 4 shows that the activation of PI3Ks-
mediated pathways by M. tuberculosis has caused several
known cellular responses as well as additional responses
such as cell survival of the macrophage, cell cycle entry,
increase of protein synthesis and increase of intracellular
Phagocytosis of bacteria in macrophages Figure 5
Figure 5a- Phagocytosis of bacteria in macrophages. The pic-
ture shows macrophages ingesting green fluorescent myco-
bacteria (indicated by arrows). The host cell membrane was 
stained by red fluorochorme PKH to define the limit of the 
cell. (The picture was provided by Zakaria Hmama)
Figure 5b- A SN-representation of the cell signaling network 
that regulates phagocytosis in the human macrophage. Both 
molecules and their interactions (non-covalent and covalent 
interactions) are represented as semantic agents and visual-
ized as nodes (with distinct icons) on the diagram. Arrows 
represent the semantic relationships between different 
agents.BMC Bioinformatics 2004, 5:156 http://www.biomedcentral.com/1471-2105/5/156
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A SN- simulator: at the beginning of the simulation Figure 6
A SN- simulator: at the beginning of the simulation. The sim-
ulation showed the actions of molecules under a biological 
scenario. 1. The initializing buttons synthesize molecules in 
each subcellular compartment. 2. The localization window 
shows molecules present in each subcellular compartment. In 
this simulation, an IgG molecule was present at the extracel-
lular space (E.S.). There were 2 ATP molecules, an Fcγ recep-
tor (FcγR), a Gab2 and a PIP2 (PI[4,5]P2) present at the 
plasma membrane (P.M.). The cytosol contained a Lyn kinase, 
a PI3K-p85 and a PI3K-p110 subunit. There was no molecule 
present at the nucleus in this simulation. 3. The "Start Simula-
tion" button creates a previously specified translocation 
event. In this simulation, the translocation has already 
occurred and moved the IgG from the extracellular space to 
the plasma membrane. 4. The "Next" button triggers a 
search that determines a proper event to occur and advances 
to the next step. 5. The pathway-viewer shows a series of 
events occurred during the simulation.
A SN- simulator: at the end of the simulation Figure 7
A SN- simulator: at the end of the simulation. The pathway-
viewer shows that the initial translocation of the IgG mole-
cule has led to the occurrence of a series of events, which 
include several non-covalent interactions, covalent interac-
tions, and translocations of various molecules: Event #1: the 
IgG was translocated from the extracellular space to the 
plasma membrane. Event #2: the IgG bound to the Fcγ recep-
tor at the plasma membrane. Event #3: the Lyn was translo-
cated from the cytosol to the plasma membrane. Event #4: 
the Lyn bound to the Fcγ receptor at the plasma membrane. 
Event #5: the Lyn phosphorylated the Gab2 to a Gab2-phos-
phate (Gab2-P) at the plasma membrane. Event #6: the PI3K-
p85 and p110 (already bound to each other) were translo-
cated together from the cytosol to the plasma membrane. 
Event #7: the PI3K-p85 bound to the Gab2-P at the plasma 
membrane. Event #8: the PI3K-p110 phosphorylated the 
PIP2 to a PIP3 (PI[3,4,5]P3) at the plasma membrane. Event 
#9: The formation of the PIP3 caused phagosome formation.
Table 4: Simulation results from M. tuberculosis invasion in the human macrophage.
Known response in the macrophage Other potential response in the macrophage
Actin Polymerization Cell survival
Pseudopod Extension Cell cycle entry – S phase
Phagosome Formation Increase of protein synthesis
Phagosome Maturation Arrest Increase of intracellular glucose levelBMC Bioinformatics 2004, 5:156 http://www.biomedcentral.com/1471-2105/5/156
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Discussion
Features of the semantic model
In the present work we have developed a semantic model
to represent the properties and the behaviors of molecules
and their interactions in the context of cell signaling path-
ways. The proposed model offers some additional fea-
tures, compared to other existing pathway models. Those
features are essential for characterizing the complex
behaviors of biological entities, and they include:
Specify the spatial organization of molecules
The semantic model has specified the hierarchical rela-
tionships among the different biological structures, from
cells to compartments, molecules and domains/sites. The
hierarchy between subcellular compartments and
molecules has allowed us to specify the spatial organiza-
tion of molecules, model the translocation events and
represent the effects of locations on the different interac-
tions among molecules.
Model proteins as integrating and logical devices
The hierarchy between molecules and their domains/sites
has enabled us to explicitly model the relationship
between forms and functions for proteins. Through the
allosteric regulation events, proteins have been modeled
and implemented as integrating and logical devices in the
semantic network, and their conformational states (out-
puts) are switched by the combination of non-covalent
ligand bindings or covalent modifications (inputs).
Provide a direct communication from models to simulations
Through the prototyping system in the semantic network,
any rule or interaction specified on a prototypical mole-
cule automatically define the properties and behaviors of
all its instances. As demonstrated by the simulator, the
semantic network provided a direct communication from
the interaction model to an application where the actions
of molecules can be observed under different scenarios.
Therefore, the semantic network is dynamic as a change of
states on a molecule can alter its function and potentially
cause a chain-reaction effect in the system.
Reduce the need for labels
In addition, the current semantic model is different from
the previous models in BioCAD. An essential difference is
the representation of functional labels or roles on pro-
teins. The meanings of functional descriptions or associa-
tion words such as "enzyme", "activator/activates" or
"inhibitor/inhibits", which are often used to characterize
the behaviors of proteins in most pathway models, have
been represented explicitly through events and relation-
ships in the developed semantic network. For example, a
protein acts as an "enzyme" if 1) the protein participates
in a "covalent interaction event", 2) the presence of a
"functional" catalytic domain on the protein is required
for the occurrence of the event, and 3) the protein itself is
not modified after the event. Similarly, a protein A "acti-
vates" a protein B if a non-covalent binding event from
protein A turns on the "functional" state of a domain/site
on protein B. Hence, the model has reduced the need for
labels, which are often confusing or misleading on con-
ventional pathway representation.
Future directions
The use of non-covalent and covalent events has enabled
us to model protein-protein interactions and chemical
modifications on molecules including proteins and
metabolites. The next challenge is to model the complex
interactions that govern gene regulations. The current con-
struction of non-covalent interaction events can model
the binding of an individual transcription factor to a par-
ticular site of a gene, and the covalent interaction event
Description of icons used in other figures Figure 8
Description of icons used in other figures.BMC Bioinformatics 2004, 5:156 http://www.biomedcentral.com/1471-2105/5/156
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can represent the transcription process that leads to the
production of an mRNA, and the translation process that
produces a protein. However, a successful transcription in
a eukaryotic cell requires the formation of a protein com-
plex that involves more than one hundred subunits, and
the complex may be assembled in various orders [53]. We
anticipate the improvement of the current allosteric
regulation model to characterize the more complex logic
in gene regulation.
The semantic network representation can be exploited for
performing analysis of cell signaling pathways. The exam-
ples of Fcγ receptor, CR and the class I PI3K demonstrated
that connections can be queried and analyzed among dif-
ferent biological entities. The semantic model is also com-
patible with other pathway models. Therefore, the
number of biological entities and interactions in the
semantic network can be greatly increased as pathway
data from existing databases is integrated. Previous study
has shown the value of combining gene expression pro-
files with protein-protein interaction networks for identi-
fying active subnetworks [54]. Similarly, data from gene
and protein expression experiments could be integrated
with the semantic network for "pathway filtering". For
instance, within a particular cell, there could be multiple
paths that connect two proteins, while each path consists
of different number of nodes. When the cell receives a sig-
nal, the shortest path, the one with the least number of
nodes that require activation, is more likely to be
"walked" than a longer path. Hence, the gene/protein
expression data will provide some estimation of an overall
protein expression and activation states to identify
"active" pathways in a cell under a given condition
In this study, the proposed semantic model has been
applied to cell signaling pathways in the macrophage as a
case study. The model is not limited to those pathways.
The hierarchical classification of the biological structures
and the events can model other cell signaling pathways for
different cells and organisms. An interactive website is
currently under development. We anticipate that through
the web, researchers can utilize the semantic network
approach for creating pathways in cells of their interest
and for analyzing any existing pathways including the
PI3K pathways of the human macrophage presented in
the paper.
The current capability and applicability of the SN 
simulator
In this study, we have developed a simple simulator to
demonstrate the dynamics of the semantic network and to
observe the actions of molecules qualitatively. In order to
perform a realistic cellular simulation in the future, three
components need to be improved. First, quantitative fac-
tors should be integrated into the model. For example
binding affinity, directly associated with non-covalent
events, will affect the probability and the duration of the
binding of molecules. Reaction kinetics, associated with
covalent events, will determine the rate of production.
Second, the two parameters, the population of molecules
and their localization, which influence the simulation
outcome, could be initialized and supported by experi-
mental data. For instance, gene expression data from
microarrays supports the relative abundance of tran-
scripts, and protein expression data supports the relative
abundance of proteins. Computer algorithms such as
PSORT [55] can assist in predicting the localization of
proteins.
Third, the proximity of molecules has been represented by
subcellular compartments in the simulation. This
approximation can be improved in two different ways.
First, a compartment can be further divided into smaller
sub-locations. Increasing the number of locations and
reducing the size of each location will improve the accu-
racy of the simulation. Second, the occurrence of non-cov-
alent events in the simulation has allowed us to identify
molecular complexes and their members effectively.
Hence, the proximity can be approximated through
molecular complexes, such that molecules in a complex
have higher probability to interact with members of the
same complex.
The simulator has demonstrated that a biological pathway
can emerge from the creation of semantic agents and their
relationships in the SN, and such a pathway represents a
series of consecutive events resulting from the activation
of a single molecule. It is anticipated that further develop-
ment will improve our ability to track and visualize differ-
ent instances of molecules participated in multiple
pathways. Hence, the occurrence of a cellular response
event can be triggered by the accumulation of certain
molecular species with particular states.
Conclusions
We concluded from our results that the semantic network
is an effective method to model cell signaling pathways.
Utilizing the semantic agents and the relationships in the
model, information on biological structures and their
interactions at different levels has been properly repre-
sented and integrated in the hierarchical and spatial
context. The reconstruction of the cell signaling network
in the macrophage has allowed qualitative investigation
of connections among various essential molecules and
reflected the cause-effect relationships among the events.
The simulation demonstrated the dynamics of the seman-
tic network, where actions of molecules are affected by
their current states and locations, and the history of events
can be traced and analyzed. In addition, changes causedBMC Bioinformatics 2004, 5:156 http://www.biomedcentral.com/1471-2105/5/156
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by the invading M. tuberculosis in the macrophage were
investigated by the simulator. As a result, the simulation
identified pathways of molecular interactions that led to
known cellular responses as well as other potential
responses during bacterial invasions.
Methods
The Visual Knowledge environment
Visual Knowledge (VK) is an application development
environment, and its implementation has been influ-
enced by the theory of semantic networks as well as other
approaches including set theory, frame system, object-ori-
ented modeling theory and systems based on networks of
active software agents [23]. Different from other passive
knowledge representation technology, VK is dynamic and
scalable, and it is capable of active representation and
integration of different domain knowledge. By
manipulating a number of fundamental classes of seman-
tic agents like "physical thing", "event" and "trigger",
models of various complexity can be constructed with VK.
In addition, VK allows the creation of "prototypes" within
each basic class of agents, and therefore it enables any
classification of agents based on their common character-
istics and behaviors.
The BioCAD software
BioCAD, a Visual Knowledge-based development envi-
ronment, is developed by Upstream Biosciences, Inc. and
customized to model biological systems [24]. The
BioCAD software provides tools for managing large-scale
biological data and for visualizing and editing biological
pathways and networks. BioCAD currently contains mil-
lions of biological concepts and hundreds of pathways
that have been integrated and curated from publicly avail-
able data sources. A locally installed client program allows
semantic agents to be created, stored and queried from a
remote central server. The BioCAD software is available
commercially, and a collaborative modeling server will be
publicly accessible soon.
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